| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |